share

Cdk2/9 Inhibitor CAS NO 507487-89-0


Unit Price:

CAS No.:507487-89-0

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Cdk2/9 Inhibitor CAS NO 507487-89-0 is a potent and selective small molecule inhibitor targeting cyclin-dependent kinases 2 and 9, key regulators of the cell cycle and transcription. This compound is a critical research tool for studying cell proliferation, apoptosis, and transcriptional control in various disease models, particularly oncology. It is essential for pharmaceutical R&D, academic research, and biotechnology companies focused on developing novel therapeutics for cancer and other proliferative disorders.

Application

  • Biochemical Research: Used as a selective inhibitor to study the specific roles and signaling pathways of CDK2 and CDK9 in vitro.
  • Cancer Research: A vital tool for investigating cell cycle arrest, inducing apoptosis, and evaluating anti-proliferative effects in various cancer cell lines.
  • Drug Discovery & Development: Serves as a reference compound or lead molecule in high-throughput screening and structure-activity relationship (SAR) studies for novel kinase inhibitors.
  • Mechanistic Studies: Employed to elucidate the mechanisms of transcriptional regulation, particularly the control of RNA polymerase II-dependent transcription.
  • Pharmacology: Used in preclinical studies to validate CDK2/9 as therapeutic targets and to assess efficacy in animal models of disease.
  • Academic Research: Fundamental for university and institutional labs exploring basic cell biology, oncology, and kinase biology.

Basic Information

Product Name Cdk2/9 Inhibitor
CAS No. 507487-89-0
Molecular Formula C₂₁H₂₀N₈O
Molecular Weight 400.44 g/mol
Synonyms CDK2/9 Inhibitor; 507487-89-0; 5-((4-Ethylpiperazin-1-yl)methyl)-N-(3-(1H-indol-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyrimidin-2-amine; AT-7519; AT7519; CDK Inhibitor AT7519; AT-7519 HCl (if applicable); Cyclin-Dependent Kinase Inhibitor AT7519
EINECS Contact for details

Quality Control

Our Cdk2/9 Inhibitor is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity for research applications. Each lot undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and residual solvent analysis. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all relevant specifications.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below under inert conditions for long-term stability. The product is hygroscopic (moisture-sensitive). Allow the vial to warm to room temperature in a desiccator before opening to prevent condensation.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Retention time corresponds to reference standard
Identification (MS) Consistent with molecular weight
Purity (HPLC) ≥98.0%
Water Content (KF) ≤1.0%
Residual Solvents (GC) Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.